Drug development is a complex and time-consuming process, fraught with challenges at every stage. To streamline this journey and increase the probability of launching a new therapeutic to market, pharmaceutical companies depend on robust preclinical development approaches. One crucial aspect of this phase is comprehensive understanding of the drug'